As a new daily pill to treat obesity has just been approved in the U.S and the makers of Mounjaro say Britain could soon ...

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds ...

PHILADELPHIA -- People who are obese often develop Type 2 diabetes, and ne side effect of that is nerve damage in the hands, feet, and legs. But there's been very little attention to this neuropathy, ...

Part of the controversy surrounding weight loss drugs like Ozempic and Mounjaro involve their side effects.

Indirect data suggest oral semaglutide outperforms orforglipron on weight loss and tolerability, with patients also favoring its treatment profile.

Ozempic, the cancer buster? Research out this week indicates that GLP-1 drugs used to treat diabetes and obesity might also have cancer-fighting benefits. Scientists at the University of California, ...

A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested. Weight-loss drugs such as Ozempic and Wegovy have soared in popularity. About one in eight U.S. adults ...

Just a few years after some TikTok videos spiked the demand, one in eight US adults has tried Ozempic (semaglutide) or another drug in its class. Glucagon-like peptide 1 (GLP-1) receptor agonist ...

Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.

Americans are jumping for jabs. Surveys show at least one in eight US adults have given GLP-1 drugs like Ozempic and Wegovy a shot, with 6% currently taking them. The miracle meds have been linked to ...

This innovative oral GLP-1 is a ‘small molecule’ medication that, unlike the Wegovy pill, doesn’t require that you take it on ...